Mirion Technologies, Inc. (MIR)
NYSEInformation TechnologyIndustrial - MachinerySnapshot 2026-10-29
NYSEInformation TechnologyIndustrial - MachinerySnapshot 2026-10-29
Research Workspace
Put MIR beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Electronic Equipment & Instruments is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is accelerating — up about 20% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 46%, softest on share dilution.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 53% in its worst 12-month stretch.
View RiskMIR depends on continued revenue growth, with margins under pressure from AI and Paragon investment. Revenue growth accelerated to 24.5% year over year in Q3, though non-GAAP EPS was inline. MIR trades at 38× P/E versus the 30× peer median. The price reflects less growth than our forecast. Lowered earnings guidance and a reset 2028 margin target threaten delivery. Our model puts the next-quarter miss probability near 25%. Peer multiples imply a price roughly in line with where it trades (about fair). Our read remains intact; this read is provisional.
Trailing returns as of 2026-10-30. MIR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 11 analysts currently covering MIR (as of Oct 2026).
Based on 4 Wall Street analysts offering 12-month price targets for MIR in the last 4 months.
Continue this research
Compare MIR with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| MIR Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Electronic Equipment & Instruments — fair value, gap to price, and forward P/E.
Compare the value case
Put MIR next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Grow revenue, including organic revenue, in 2026
Q3 revenue exceeded expectations, supporting 2026 growth, though the headline provides limited detail.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $18.37
The last 12 months of price, then the range of analyst 12-month targets from today’s $18.37.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.

Threatens: Expand adjusted EBITDA and margins
Higher investment resets the 2028 margin target, tempering growth outlook despite strong 2026 revenue projections.

Lowered earnings guidance threatens delivery of growth and profitability objectives, but does not alone break the thesis.
